Literature DB >> 33704493

Cognitive outcomes in patients with low-grade glioma.

Daniel M Trifiletti1, Paul D Brown2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33704493      PMCID: PMC8099460          DOI: 10.1093/neuonc/noab033

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  9 in total

1.  Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.

Authors:  Jan C Buckner; Edward G Shaw; Stephanie L Pugh; Arnab Chakravarti; Mark R Gilbert; Geoffrey R Barger; Stephen Coons; Peter Ricci; Dennis Bullard; Paul D Brown; Keith Stelzer; David Brachman; John H Suh; Christopher J Schultz; Jean-Paul Bahary; Barbara J Fisher; Harold Kim; Albert D Murtha; Erica H Bell; Minhee Won; Minesh P Mehta; Walter J Curran
Journal:  N Engl J Med       Date:  2016-04-07       Impact factor: 91.245

2.  Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.

Authors:  Paul D Brown; Stephanie Pugh; Nadia N Laack; Jeffrey S Wefel; Deepak Khuntia; Christina Meyers; Ali Choucair; Sherry Fox; John H Suh; David Roberge; Vivek Kavadi; Soren M Bentzen; Minesh P Mehta; Deborah Watkins-Bruner
Journal:  Neuro Oncol       Date:  2013-08-16       Impact factor: 12.300

3.  Dose-Dependent Cortical Thinning After Partial Brain Irradiation in High-Grade Glioma.

Authors:  Roshan Karunamuni; Hauke Bartsch; Nathan S White; Vitali Moiseenko; Ruben Carmona; Deborah C Marshall; Tyler M Seibert; Carrie R McDonald; Nikdokht Farid; Anithapriya Krishnan; Joshua Kuperman; Loren Mell; James B Brewer; Anders M Dale; Jona A Hattangadi-Gluth
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-10-21       Impact factor: 7.038

4.  Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.

Authors:  M J van den Bent; D Afra; O de Witte; M Ben Hassel; S Schraub; K Hoang-Xuan; P-O Malmström; L Collette; M Piérart; R Mirimanoff; A B M F Karim
Journal:  Lancet       Date:  2005 Sep 17-23       Impact factor: 79.321

5.  Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Authors:  Jaap C Reijneveld; Martin J B Taphoorn; Corneel Coens; Jacoline E C Bromberg; Warren P Mason; Khê Hoang-Xuan; Gail Ryan; Mohamed Ben Hassel; Roelien H Enting; Alba A Brandes; Antje Wick; Olivier Chinot; Michele Reni; Guy Kantor; Brian Thiessen; Martin Klein; Eugenie Verger; Christian Borchers; Peter Hau; Michael Back; Anja Smits; Vassilis Golfinopoulos; Thierry Gorlia; Andrew Bottomley; Roger Stupp; Brigitta G Baumert
Journal:  Lancet Oncol       Date:  2016-09-27       Impact factor: 41.316

6.  Microstructural Injury to Corpus Callosum and Intrahemispheric White Matter Tracts Correlate With Attention and Processing Speed Decline After Brain Radiation.

Authors:  Minh-Phuong Huynh-Le; Michelle D Tibbs; Roshan Karunamuni; Mia Salans; Kathryn R Tringale; Anthony Yip; Michael Connor; Aaron B Simon; Lucas K Vitzthum; Anny Reyes; Anna Christina Macari; Vitali Moiseenko; Carrie R McDonald; Jona A Hattangadi-Gluth
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-01-04       Impact factor: 8.013

7.  Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.

Authors:  Paul D Brown; Vinai Gondi; Stephanie Pugh; Wolfgang A Tome; Jeffrey S Wefel; Terri S Armstrong; Joseph A Bovi; Cliff Robinson; Andre Konski; Deepak Khuntia; David Grosshans; Tammie L S Benzinger; Deborah Bruner; Mark R Gilbert; David Roberge; Vijayananda Kundapur; Kiran Devisetty; Sunjay Shah; Kenneth Usuki; Bethany Marie Anderson; Baldassarre Stea; Harold Yoon; Jing Li; Nadia N Laack; Tim J Kruser; Steven J Chmura; Wenyin Shi; Snehal Deshmukh; Minesh P Mehta; Lisa A Kachnic
Journal:  J Clin Oncol       Date:  2020-02-14       Impact factor: 50.717

8.  Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033.

Authors:  Martin Klein; A Josephine Drijver; Martin J van den Bent; Jacolien C Bromberg; Khê Hoang-Xuan; Martin J B Taphoorn; Jaap C Reijneveld; Mohamed Ben Hassel; Elodie Vauleon; Daniëlle B P Eekers; Tzahala Tzuk-Shina; Anna Lucas; Salvador Villà Freixa; Vasilis Golfinopoulos; Thierry Gorlia; Andreas F Hottinger; Roger Stupp; Brigitta G Baumert
Journal:  Neuro Oncol       Date:  2021-05-05       Impact factor: 12.300

9.  Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Authors:  Brigitta G Baumert; Monika E Hegi; Martin J van den Bent; Andreas von Deimling; Thierry Gorlia; Khê Hoang-Xuan; Alba A Brandes; Guy Kantor; Martin J B Taphoorn; Mohamed Ben Hassel; Christian Hartmann; Gail Ryan; David Capper; Johan M Kros; Sebastian Kurscheid; Wolfgang Wick; Roelien Enting; Michele Reni; Brian Thiessen; Frederic Dhermain; Jacoline E Bromberg; Loic Feuvret; Jaap C Reijneveld; Olivier Chinot; Johanna M M Gijtenbeek; John P Rossiter; Nicolas Dif; Carmen Balana; Jose Bravo-Marques; Paul M Clement; Christine Marosi; Tzahala Tzuk-Shina; Robert A Nordal; Jeremy Rees; Denis Lacombe; Warren P Mason; Roger Stupp
Journal:  Lancet Oncol       Date:  2016-09-27       Impact factor: 54.433

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.